11:15-11:30
Exploring the heterogeneity of endocrine progenitors in stem cell-islet differentiation
Mandala Ajie, Leiden

11:30-11:45
Beta cell mass and function, pancreatic volume and -fat differences between short- and long-duration type 1 diabetes: a detailed PET/CT imaging study
Sevilay Tokgöz, Nijmegen

11:45-12:00
Prolonged Hypoglycaemia in Type 1 Diabetes: Suspected Anti-Insulin Antibody Mediated Alteration of Insulin Pharmacokinetics During a Multidisciplinary Treatment Program
Helen Lutgers, Groningen

12:00-12:15
OGTT-derived muscle and liver insulin sensitivity indices reflect skeletal muscle but not hepatic glucose uptake in prediabetes
Mijke Buitinga, Maastricht

12:15-12:30
The presence of T2DM increases the risk for liver fibrosis superimposed to other cardiometabolic risk factors in the GRIPonMASH screening cohort
Vivian de Jong, Julius Clinical

12:30-12:45
Composite lifestyle risk score is associated with higher controlled attenuation parameter: preliminary GRIPonMASH results
Ioanna Panagiota Kalafati, Athens, Greece

12:45-13:00
Menopause transition is associated with worsening of glucose management in women with or without diabetes – The Maastricht study
Lisa den Brok, Maastricht

11:15-11:30
Methylglyoxal is linked to poor glycaemic control in individuals with type 1 diabetes
Oluwatomisono Akinrimisi, Amsterdam

11:30-11:45
Glucose swings and heart rate rhythms: inverse association between glycaemic variability and heart rate variability in people with type 1 diabetes
Eleen Schupp, Nijmegen

11:45-12:00
Effect of 12 weeks of inulin supplementation on glycaemic control and immunological parameters in type 1 diabetes (the INCREASE study)
Lente Blok, Amsterdam

12:00-12:15
The effect of repeated meal ingestion on whole-body insulin sensitivity and substrate oxidation in individuals with and without type 2 diabetes
Gül Turan, Wageningen

12:15-12:30
The natural metabolite 6-bromo-tryptophan associates with metabolic health and ameliorates adiposity and glucose metabolism in vivo
Nadia Romp, Amsterdam

12:30-12:45
Leukocyte counts are lower in people with type 1 diabetes with high glycaemic variability
Tijmen van der Ent, Nijmegen

12:45-13:00
Perioperative glucose, HbA1c and postoperative outcomes in surgical patients with diabetes mellitus
Ayla Stobbe, Amsterdam

11:15-11:30
Development and psychometric evaluation of a questionnaire, measuring expectations related to AI-driven bolus advisors among people with diabetes
Nefeli Dimitropoulou, Maastricht

11:30-11:45
Exploring healthcare professionals’ experiences, cognitions and emotions in working with advanced diabetes technology
Wiebke Kantimm, Tilburg

11:45-12:00
The associations between health literacy and patient-reported outcomes in adults with insulin treated diabetes: early findings from the EDUCATE Study
Cassy Dingena, Maastricht

12:00-12:15
The Association between Stressful Life Events and the Development of Chronic Disease Multimorbidity: Findings from the New Hoorn Study
Romain Meer, Amsterdam

12:15-12:30
Higher BMI is associated with more financial difficulties, loneliness, and stress: insights from a novel nationwide screening tool
Renate Meeusen, Rotterdam

14:00-14:15
Randomized Trial of a Dual-Hormone Fully Closed-Loop in Adults with Type 1 Diabetes
Milena Jancev, Utrecht

14:15-14:30
Hybrid closed-loop systems substantially improve glycaemic control of people with type 1 diabetes within six months of use in a real-world setting
Jill Jansen, Nijmegen

14:30-14:45
From routine checkups to dynamic diabetes care: telemonitoring-supported personalized follow-up in type 1 diabetes
Renée Paijmans-Hovenier, Anna Ziekenhuis

14:45-15:00
Foot infrared thermography: Impact of methodology and repeatability of a multi-view setup in healthy individuals
Janneke Lukkezen, Nijmegen

15:00-15:15
Conversational Nutrition: the enhancement of dietary assessment with an AIdriven chatbot
Lotte Peters, Twente/TNO

15:15-15:30
CloudCare, riskstratified remote patient monitoring in diabetes care; interim analysis of a cohort study
Koen van Beers, Diabeter

15:30-15:45
Toward minimally invasive diabetes subtyping in type 2 (pre)diabetes: comparison of a traditional and a modified oral glucose tolerance test
Karleen Pietersma, TNO

14:00-14:15
Glucose variability induces inflammatory and metabolic transcriptional changes in human macrophages
Manon Dumont, Nijmegen

14:15-14:30
Hypoxia-induced PHD1 inactivation protects stressed βcells by modulating the type I interferon response
Raphael Fagundes Rosa, Leiden

14:30-14:45
Adrenergic blockade suppresses inflammatory responses to hypoglycaemia
Marijn Hendriksz, Nijmegen

14:45-15:00
Unraveling Differences in Glucocorticoid Regulation between South Asians and Europids
Ceyda Ilhan, Rotterdam

15:00-15:15
Postprandial Inflammation Is Shaped by Dietary Fatty Acid Composition: Insights from a Double-Blind Randomized Crossover Trial
Britta Naus, Wageningen

15:15-15:30
Semaglutide improves glycemic control and weight but not methylglyoxal-associated stress in type 2 diabetes
Maya Stelzer, Amsterdam

14:00-14:15
Higher ultra-processed food intake is associated with less time in euglycaemic range, unfavourable cardiometabolic risk factors and a less diverse faecal microbiome in 427 adults with DM1
Lente Blok, Amsterdam

14:15-14:30
Cardiovascular risk factors and population attributable fractions for dementia in midlife and late-life among individuals with type 2 diabetes: a nationwide Swedish registry study
Jan de Leijer, Utrecht

14:30-14:45
After-dinner snack is associated with total body fat and insulin resistance in a middle-aged population with overweight: a cross-sectional analysis in the NEO study
Soraya de Kam, Maastricht

14:45-15:00
Usage and Acceptance of the Diameter eHealth Lifestyle Intervention for People with Type 2 Diabetes
Chiara Lansink, Twente

15:00-15:15
Glucocorticoid sensitivity and cardiometabolic health: A longitudinal study
Robin Lengton, Rotterdam

15:15-15:30
Adrenaline partly mediates the pro-thrombotic effect of hypoglycaemia
Ilyas Mustafajev, Nijmegen

15:30-15:45
Prediction effectiveness of a lifestyle intervention based on multidisciplinary regression analysis of individuals with overweight and obesity
Eva Vanbrabant, Maastricht

11:30-11:45
Diagnostic Utility of Serial Radiography in Foot Osteomyelitis in People with Diabetes: Influence of Operator Experience on Test Performance
Henry Harrison, Amsterdam

11:45-12:00
Atypical diabetes in Dutch primary healthcare: Evaluation of a precision diabetes diagnosis toolbox for primary healthcare professionals
Roxanna Hauck, Leiden

12:00-12:15
Trends in the prevalence of prediabetes, and (undiagnosed) type 2 diabetes in the Netherlands
Donald Malestein, Rotterdam

12:15-12:30
Hospital admission profiles of Dutch people with diabetes
Vivienne Lit, Leiden

12:30-12:45
Real-World Effects of GLP-1 Receptor Agonists versus Other Antihyperglycemic Medication on Cardiovascular Risk Factors
Welmoed Marra, Nijmegen

12:45-13:00
Incidence and prevalence of type 1 diabetes mellitus in the PHARMO Data Network in the Netherlands
Jelena Pavlović, PHARMO

13:00-13:15
Eighteen-Year Experience with Allogeneic Islet Transplantation in the Netherlands
Willemijn de Vos, Leiden

11:30-11:45
Pyridoxamine supplementation improves microvascular outcomes in type 2 diabetes: a double-blind randomized placebo-controlled crossover trial
Michelle van Oeteren, Maastricht

11:45-12:00
Digital biomarkers for cardiometabolic health in type 2 diabetes
Kristel Kamstra, TNO

12:00-12:15
Carotid Stiffness Is Associated with Worse Cognitive Functioning in Participants with Type 2 Diabetes: The Maastricht Study
Jie Shen, Maastricht

12:15-12:30
Symptom responses to hypoglycemia are unaffected by adrenergic blockade
Rick Meijer, Nijmegen

12:30-12:45
Associations of specialized pro-resolving mediators with incident myocardial infarction by type 2 diabetes: a case-control within The Maastricht Study
Elena Tore, Maastricht

12:45-13:00
Hair Glucocorticoid Levels and Trajectories of Metabolic Syndrome Components: a 7-Year Longitudinal Study
Susanne Kuckuck, Rotterdam

13:00-13:15
Comparative clinical pharmacokinetics of Metformin hydrochloride 500 mg, prolonged release granules versus Metformin hydrochloride XR 500 mg, extended release tablets: single dose crossover study
Oscar Natan, Hubrecht Institute

11:30-11:45
Insulin sensitivity and metabolic profiles during pregnancy and postpartum
Puspito Arum, Groningen

11:45-12:00
Naltrexone/bupropion enhances improvement in hepatic steatosis during a 56-week lifestyle intervention in adults with overweight/obesity
Carmen Dietvorst, Rotterdam

12:00-12:15
Intestinal Reg1B is upregulated by the commensal Anaerobutyricum soehngenii strain and ameliorates insulin signaling and liver steatosis in a murine model of obesity
Youling Hao, Amsterdam

12:15-12:30
Identifying multidisciplinary risk factors for obesity in a Dutch cohort of individuals varying in body weight
Jikke Hesen, Maastricht

12:30-12:45
Hepatic steatosis and fibrosis improvement in subjects with and without diabetes assessed with different non-invasive tests one year after bariatric surgery
Laura Konings, Rotterdam

12:45-13:00
Desulfovibrio fructosovorans Reprograms Intestinal Fructose Metabolism and Reduces Adiposity in Diet-Induced Obese Mice
Jakshana Ananthasabesan, Amsterdam

13:00-13:15
Real-world effectiveness and dosing patterns of tirzepatide for overweight and obesity: A multicentre retrospective observational study
Puck van den Hooff, Nijmegen